GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Marketable Securities

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Marketable Securities : HK$0.0 Mil (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Shenzhen Neptunus Interlong Bio-Technique Co's Marketable Securities for the quarter that ended in Dec. 2024 was HK$0.0 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co's annual Marketable Securities declined from Dec. 2022 (HK$67.0 Mil) to Dec. 2023 (HK$10.9 Mil) and declined from Dec. 2023 (HK$10.9 Mil) to Dec. 2024 (HK$0.0 Mil).


Shenzhen Neptunus Interlong Bio-Technique Co Marketable Securities Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Marketable Securities Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.74 102.86 67.00 10.94 -

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.51 - 10.94 86.12 -

Shenzhen Neptunus Interlong Bio-Technique Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Shenzhen Neptunus Interlong Bio-Technique Co  (HKSE:08329) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Shenzhen Neptunus Interlong Bio-Technique Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Interlong Bio-Technique Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Traded in Other Exchanges
N/A
Address
979 King’s Road, 43rd Floor, One Taikoo Place, Quarry Bay, Hong Kong, HKG
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines